发明名称 ANTI-CTLA-4 ANTIBODY COMPOSITION
摘要 <P>PROBLEM TO BE SOLVED: To provide a new anti-CTLA-4 antibody composition containing a chelating agent and a cure using the new anti-CTLA antibody composition for diseases and symptoms (among which various new diseases are included). <P>SOLUTION: The anti-CTLA-4 antibody composition of the invention is characterized by containing (a) at least one chelating agent and (b) at least one antibody containing an amino-acid sequence of which at least 90% is identical to a heavy-chain amino-acid sequence indicated by sequence ID No. 2 and an amino-acid sequence of which at least 90% is identical to a light-chain amino-acid sequence indicated by sequence ID No. 4, wherein the above antibody binds to human CTLA-4. <P>COPYRIGHT: (C)2006,JPO&NCIPI
申请公布号 JP2006249081(A) 申请公布日期 2006.09.21
申请号 JP20060056701 申请日期 2006.03.02
申请人 PHARMACIA & UPJOHN CO LLC 发明人 ABATE JUSTIN DONALD;DAS TAPAN KANTI;ELLIOTT CARRIE MARIE;MUTHURANIA KEVIN WAMITI;NEMA SANDEEP;SINGH SATISH KUMAR
分类号 A61K38/00;A61K39/395;A61K47/18;A61K47/22;A61K47/26;A61K47/34;A61P35/00;C07K16/28;C07K16/46;C12N15/09;C12P21/08 主分类号 A61K38/00
代理机构 代理人
主权项
地址